3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
25
Phase 1
21
Phase 1/2
15
Phase NA
8
Phase 3
3
Phase EARLY_PHASE1
2
Phase 2/3
2
Status
Unknown
1
Terminated
1
Active not recruiting
1
Sponsor Class
INDUSTRY
7
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Other hematologic neoplasm
3
Lymphoid
3
Conditions
Breast Neoplasms
552
Colorectal Neoplasms
246
Neoplasms
232
Prostatic Neoplasms
221
Carcinoma, Non-Small-Cell Lung
196
Stomach Neoplasms
153
Leukemia, Myeloid, Acute
149
Carcinoma, Hepatocellular
147
Lung Neoplasms
137
Rectal Neoplasms
135
Multiple Myeloma
133
Nasopharyngeal Carcinoma
112
Colonic Neoplasms
106
Neoplasm Metastasis
100
Precursor Cell Lymphoblastic Leukemia-Lymphoma
86
Lymphoma
85
Uterine Cervical Neoplasms
83
Pancreatic Neoplasms
82
Lymphoma, Large B-Cell, Diffuse
79
Ovarian Neoplasms
78
Leukemia
78
Head and Neck Neoplasms
77
Esophageal Neoplasms
74
Lymphoma, Follicular
72
Brain Neoplasms
70
Squamous Cell Carcinoma of Head and Neck
65
Recurrence
64
Leukemia, Lymphocytic, Chronic, B-Cell
59
Lymphoma, Non-Hodgkin
58
Pain
56
Interventions
venetoclax
1
ofatumumab
1
obinutuzumab
1
ibrutinib
1
Cholecalciferol
1
Chlorambucil
1
Bendamustine Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 3
×
OTHER
×
Leukemia, B-Cell
×
Clear all
NCT04608318
2026-04-30
CLL17
German CLL Study Group
Phase 3
Active not recruiting
897 enrolled
NCT01518959
2020-07-16
D-HEM
Semmelweis University
Phase 3
Terminated
31 enrolled
NCT01678430
2012-10-15
RIAltO
University of Liverpool
Phase 3
Unknown
670 enrolled